Published in Pharmacoepidemiol Drug Saf on June 04, 2012
Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort. BMC Pregnancy Childbirth (2015) 0.76
Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011. Birth Defects Res A Clin Mol Teratol (2016) 0.75
A method to automate probabilistic sensitivity analyses of misclassified binary variables. Int J Epidemiol (2005) 5.17
Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol (2005) 3.37
Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol (1986) 3.34
Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol (1990) 2.71
Remember that? A comparison of real-time versus retrospective recall of smoking lapses. J Consult Clin Psychol (1997) 2.57
Bias from nondifferential but dependent misclassification of exposure and outcome. Epidemiology (1992) 2.11
Multivitamin supplementation and risk of birth defects. Am J Epidemiol (1999) 1.91
Toward a psychology of memory accuracy. Annu Rev Psychol (2000) 1.75
The retrospective measurement of prenatal and perinatal events: accuracy of maternal recall. Schizophr Res (2004) 1.75
Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA (1981) 1.64
Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol (1999) 1.60
Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. Teratology (1989) 1.23
Self-reported confidence in recall as a predictor of validity and repeatability of physical activity questionnaire data. Epidemiology (2009) 1.00
Demographics, health behaviors, and past drug use as predictors of recall accuracy for previous prescription medication use. J Clin Epidemiol (1997) 0.99
Drug certainty-response in interview-based studies. Pharmacoepidemiol Drug Saf (2011) 0.98
Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf (2006) 0.97
The impact of differential recall on the results of case-control studies. Int J Epidemiol (1990) 0.89
Agreement between patient self-report and a Veterans Affairs national pharmacy database for identifying recent exposures to antibiotics. Pharmacoepidemiol Drug Saf (2003) 0.88
Predictors of self-reported confidence ratings for adult recall of early life sun exposure. Am J Epidemiol (2005) 0.87
Strategic regulation of grain size in memory reporting. J Exp Psychol Gen (2002) 0.85
Selecting accurate statements from the cognitive interview using confidence ratings. J Exp Psychol Appl (2002) 0.83
Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA (2002) 10.03
Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol (2002) 9.76
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 5.91
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med (2007) 4.25
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol (2011) 3.42
Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol (2005) 3.37
Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics (2002) 2.90
Recent trends in use of herbal and other natural products. Arch Intern Med (2005) 2.65
Prevalence and characteristics of opioid use in the US adult population. Pain (2008) 2.49
Identification of phthalates in medications and dietary supplement formulations in the United States and Canada. Environ Health Perspect (2011) 2.40
Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14
Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception. Am J Epidemiol (2008) 1.97
Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol (2005) 1.78
Induced Abortions and the Risk of Preeclampsia Among Nulliparous Women. Am J Epidemiol (2015) 1.76
Periconceptional use of opioids and the risk of neural tube defects. Obstet Gynecol (2013) 1.76
Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol (2008) 1.69
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot. Epidemiology (2014) 1.54
Erythromycin use during pregnancy in relation to pyloric stenosis. Am J Obstet Gynecol (2002) 1.50
Medications as a potential source of exposure to phthalates in the U.S. population. Environ Health Perspect (2008) 1.45
Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol (2014) 1.45
Medication use among children <12 years of age in the United States: results from the Slone Survey. Pediatrics (2009) 1.41
Antiherpetic medication use and the risk of gastroschisis: findings from the National Birth Defects Prevention Study, 1997-2007. Paediatr Perinat Epidemiol (2013) 1.40
Cough and cold medication use by US children, 1999-2006: results from the slone survey. Pediatrics (2008) 1.36
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry (2009) 1.34
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol (2002) 1.27
Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics (2007) 1.26
Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology. Pediatr Infect Dis J (2006) 1.26
Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf (2013) 1.25
Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am J Epidemiol (2002) 1.25
Management of acute otitis media by primary care physicians: trends since the release of the 2004 American Academy of Pediatrics/American Academy of Family Physicians clinical practice guideline. Pediatrics (2007) 1.24
Use of herbal treatments in pregnancy. Am J Obstet Gynecol (2010) 1.23
Herbal use before and during pregnancy. Am J Obstet Gynecol (2009) 1.21
Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol (2007) 1.19
Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A (2009) 1.17
Association of vasoconstrictive exposures with risks of gastroschisis and small intestinal atresia. Epidemiology (2003) 1.14
Safety of macrolides during pregnancy. Am J Obstet Gynecol (2012) 1.13
Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol (2009) 1.12
Sleep position of low birth weight infants. Pediatrics (2003) 1.12
Validity of parental reporting of recent episodes of acute otitis media: a Slone Center Office-Based Research (SCOR) Network study. J Am Board Fam Med (2007) 1.11
Folic acid intake and spina bifida in the era of dietary folic acid fortification. Epidemiology (2011) 1.09
Comments on: are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. Pharmacoepidemiol Drug Saf (2014) 1.08
Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring. Am J Epidemiol (2016) 1.08
Use of antiepileptic medications in pregnancy in relation to risks of birth defects. Ann Epidemiol (2011) 1.08
Low maternal alcohol consumption during pregnancy and oral clefts in offspring: the Slone Birth Defects Study. Birth Defects Res A Clin Mol Teratol (2003) 1.06
Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A (2009) 1.05
Use of postmenopausal hormone therapy since the Women's Health Initiative findings. Pharmacoepidemiol Drug Saf (2005) 1.05
Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study. Drug Alcohol Depend (2010) 1.04
Vasoactive exposures, vascular events, and hemifacial microsomia. Birth Defects Res A Clin Mol Teratol (2004) 1.03
Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine (2013) 1.03
Epidemiologic analysis of maternal factors and amniotic band defects. Birth Defects Res A Clin Mol Teratol (2003) 1.01
Maternal dietary glycemic intake and the risk of neural tube defects. Am J Epidemiol (2009) 1.01
Secular changes in sleep position during infancy: 1995-1998. Pediatrics (2003) 1.00
Effect of high parity on occurrence of anemia in pregnancy: a cohort study. BMC Pregnancy Childbirth (2011) 0.99
Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System. Am J Obstet Gynecol (2011) 0.99
Use of herbal/natural supplements according to racial/ethnic group. J Altern Complement Med (2006) 0.98
Drug certainty-response in interview-based studies. Pharmacoepidemiol Drug Saf (2011) 0.98
Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology (2005) 0.98
Descriptive epidemiology of idiopathic clubfoot. Am J Med Genet A (2013) 0.98
Case-crossover and case-time-control designs in birth defects epidemiology. Am J Epidemiol (2003) 0.98
Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol (2011) 0.98
Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Res A Clin Mol Teratol (2004) 0.98
Demographic and reproductive factors associated with hemifacial microsomia. Cleft Palate Craniofac J (2004) 0.97
Pseudoephedrine use among US children, 1999-2006: results from the Slone survey. Pediatrics (2008) 0.97
Gestational hypertension in pregnancies supported by infertility treatments: role of infertility, treatments, and multiple gestations. Fertil Steril (2007) 0.96
Nausea and vomiting in pregnancy: maternal characteristics and risk factors. Paediatr Perinat Epidemiol (2006) 0.96
Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology (2009) 0.96
Frequency of bed sharing and its relationship to breastfeeding. J Dev Behav Pediatr (2004) 0.95
Psychosocial functioning in children with and without orofacial clefts and their parents. Cleft Palate Craniofac J (2011) 0.94
Racial/ethnic disparities in the diagnosis of otitis media in infancy. Int J Pediatr Otorhinolaryngol (2004) 0.94
Tolerability of oral xylitol solution in young children: implications for otitis media prophylaxis. Int J Pediatr Otorhinolaryngol (2006) 0.94
Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A Clin Mol Teratol (2008) 0.93
Maternal exposure to statins and risk for birth defects: a case-series approach. Am J Med Genet A (2008) 0.93